• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项安慰剂对照双盲研究,考察一种金丝桃制剂对105名轻度抑郁症患者的疗效。

Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients.

作者信息

Sommer H, Harrer G

机构信息

Psychiatrische Fachpraxis, Universität Salzburg, Austria.

出版信息

J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S9-11. doi: 10.1177/089198879400700104.

DOI:10.1177/089198879400700104
PMID:7857516
Abstract

One hundred and five outpatients with mild depressions of short duration were treated in a double-blind study with either 3 x 300 mg hypericum extract or placebo. The therapy phase was 4 weeks. The effectiveness was judged according to the Hamilton Depression Scale after 2 and 4 weeks. The values of the mean basic score in these periods fell from 15.8 to 9.6 or 7.2 in the active group, and in the placebo group, from 15.8 to 12.3 and 11.3. The differences between active and placebo groups were statistically significant with P < .05 and P < .01 achieved after 2 and 4 weeks, respectively. In the active group, 28 of 42 patients (67%) and, in the placebo group, 13 of 47 patients (28%) responded to treatment. Notable side effects were not found.

摘要

105例病程较短的轻度抑郁症门诊患者参与了一项双盲研究,他们被随机分为两组,分别服用3次每次300毫克的金丝桃提取物或安慰剂。治疗阶段为4周。在2周和4周后,根据汉密尔顿抑郁量表来判断疗效。在这些时间段内,治疗组的平均基础评分从15.8降至9.6或7.2,而安慰剂组则从15.8降至12.3和11.3。治疗组和安慰剂组之间的差异具有统计学意义,分别在2周和4周后P值小于0.05和P值小于0.01。治疗组中,42例患者中有28例(67%)对治疗有反应,安慰剂组中,47例患者中有13例(28%)对治疗有反应。未发现明显的副作用。

相似文献

1
Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients.一项安慰剂对照双盲研究,考察一种金丝桃制剂对105名轻度抑郁症患者的疗效。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S9-11. doi: 10.1177/089198879400700104.
2
Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study.金丝桃提取物LI 160与马普替林相比的有效性和耐受性:一项多中心双盲研究。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S24-8. doi: 10.1177/089198879400700108.
3
Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients.金丝桃提取物LI 160与丙咪嗪相比的有效性和耐受性:135名门诊患者的随机双盲研究。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S19-23. doi: 10.1177/089198879400700107.
4
Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.金丝桃提取物LI 160的益处与风险:3250例患者的药物监测研究
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S34-8. doi: 10.1177/089198879400700110.
5
Hypericum treatment of mild depressions with somatic symptoms.金丝桃属植物治疗伴有躯体症状的轻度抑郁症。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S12-4. doi: 10.1177/089198879400700105.
6
Multicenter double-blind study examining the antidepressant effectiveness of the hypericum extract LI 160.一项多中心双盲研究,旨在考察金丝桃提取物LI 160的抗抑郁效果。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S15-8. doi: 10.1177/089198879400700106.
7
LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial.圣约翰草提取物LI 160与阿米替林治疗轻至中度抑郁门诊患者的对照6周临床试验。
Pharmacopsychiatry. 1997 Sep;30 Suppl 2:77-80. doi: 10.1055/s-2007-979523.
8
Clinical investigation of the antidepressant effectiveness of hypericum.金丝桃属植物抗抑郁效果的临床研究
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S6-8. doi: 10.1177/089198879400700103.
9
Effects of hypericum extract on the sleep EEG in older volunteers.金丝桃提取物对老年志愿者睡眠脑电图的影响。
J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S39-43. doi: 10.1177/089198879400700111.
10
Treatment of seasonal affective disorder (SAD) with hypericum extract.用金丝桃属植物提取物治疗季节性情感障碍(SAD)。
Pharmacopsychiatry. 1997 Sep;30 Suppl 2:89-93. doi: 10.1055/s-2007-979526.

引用本文的文献

1
Understanding the research landscape of over-the-counter herbal products, dietary supplements, and medications evaluated for depressive symptoms in adults: a scoping review.了解针对成人抑郁症状评估的非处方草药产品、膳食补充剂和药物的研究现状:一项范围综述。
Front Pharmacol. 2025 Jul 15;16:1609605. doi: 10.3389/fphar.2025.1609605. eCollection 2025.
2
Flavonoids against depression: a comprehensive review of literature.黄酮类化合物与抑郁症:文献综述
Front Pharmacol. 2024 Oct 16;15:1411168. doi: 10.3389/fphar.2024.1411168. eCollection 2024.
3
Current state of research on the clinical benefits of herbal medicines for non-life-threatening ailments.
草药对非危及生命疾病临床益处的研究现状
Front Pharmacol. 2023 Sep 28;14:1234701. doi: 10.3389/fphar.2023.1234701. eCollection 2023.
4
Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders.精神疾病中血清素能和去甲肾上腺素能系统功能障碍与躯体症状
Front Psychiatry. 2019 May 21;10:286. doi: 10.3389/fpsyt.2019.00286. eCollection 2019.
5
Pharmacological interventions for somatoform disorders in adults.成人躯体形式障碍的药物干预
Cochrane Database Syst Rev. 2014 Nov 7;2014(11):CD010628. doi: 10.1002/14651858.CD010628.pub2.
6
St John's wort for major depression.用于治疗重度抑郁症的圣约翰草。
Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD000448. doi: 10.1002/14651858.CD000448.pub3.
7
Placebo controlled continuation treatment with Hypericum extract WS 5570 after recovery from a mild or moderate depressive episode.轻度或中度抑郁发作康复后使用金丝桃提取物 WS 5570 进行安慰剂对照的延续治疗。
Wien Med Wochenschr. 2007;157(13-14):362-6. doi: 10.1007/s10354-007-0441-7.
8
Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].与安慰剂相比,圣约翰草提取物WS 5570对重度抑郁症患者疗效更佳:一项随机、双盲、安慰剂对照、多中心试验[ISRCTN77277298]
BMC Med. 2006 Jun 23;4:14. doi: 10.1186/1741-7015-4-14.
9
St John's wort for depression--an overview and meta-analysis of randomised clinical trials.圣约翰草治疗抑郁症——随机临床试验的综述与荟萃分析
BMJ. 1996 Aug 3;313(7052):253-8. doi: 10.1136/bmj.313.7052.253.